Private company
Oncorus, Inc.
American pharmaceutical preparations company, incorporated in Delaware.
Last updated Oct 18, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
No quarterly figures reported.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Cash | $20.1M3 | $45.3M3 | $130.3M4 | $100.8M5 | $25.7M5 | |
| Current assets | $45.9M3 | $133.4M4 | $129.1M5 | $64.6M5 | ||
| Total assets | $50.8M3 | $182.3M4 | $201.6M5 | $145.6M5 | ||
| Current liabilities | $4.9M3 | $6.0M4 | $21.0M5 | $37.2M5 | ||
| Long-term debt | $05 | $20.0M5 | ||||
| Total liabilities | $8.5M3 | $47.6M4 | $71.6M5 | $85.1M5 | ||
| Shareholders’ equity | -$40.1M3 | -$74.3M4 | $134.7M5 | $130.0M5 | $60.5M5 | |
| Shares outstanding | 989.0K shares3 | 22.6M shares4 | 25.8M shares5 | 26.1M shares5 | 26.1M shares7 |
Leadership
Who has led Oncorus, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
2025
- Chief executive officerTheodore Ashburn Oct 1, 2020 to Mar 2, 20228
- PresidentTheodore Ashburn Oct 1, 2020 to Mar 2, 20228
- Chief financial officerAlexander Nolte May 22, 2023 to May 22, 20239
- Chief financial officerRick Wanstall May 12, 2022 to May 25, 202210
- Chief operating officerStephen Harbin Dec 9, 2020 to Nov 2, 202211
Board members and other officers (12)
- CSO and SVP, ResearchChristophe Queva Oct 1, 2020 to Mar 2, 202212
- Board memberDouglas Fambrough Jun 24, 2022 to Jun 24, 202213
- Board memberEric Rubin Jun 17, 2021 to Jun 24, 202214
- Board memberBarbara Yanni Jul 29, 2021 to Jun 24, 202215
- Board memberBriggs Morrison Oct 1, 2020 to Oct 1, 202016
- Board memberCameron Wheeler Oct 1, 2020 to Oct 1, 202017
- Board memberLuke Evnin Oct 1, 2020 to Jun 24, 202218
- Board memberMary Kay Fenton Oct 1, 2020 to Jun 24, 202219
- Board memberMitchell H. Finer Oct 1, 2020 to Jun 24, 202220
- Board memberSpencer Nam Oct 1, 2020 to Jun 24, 202221
- Board memberTheodore Ashburn Oct 1, 2020 to Mar 2, 20228
- Board memberScott A. Canute Dec 16, 2020 to Jun 24, 202222
Timeline
- Oct 1, 2020New chief executive Theodore Ashburn becomes CEO8
Recent filings
- Aug 3, 20238-K
- Jul 28, 20238-K
- Jul 19, 20238-K
- Jun 26, 20238-K
- Jun 23, 2023DEF 14A
- Jun 16, 20233 FORM 3 SUBMISSION
- Jun 9, 20238-K
- Jun 7, 20238-K
- Jun 1, 20238-K
- May 22, 20238-K
- May 22, 202310-Q
- May 22, 20233 FORM 3 SUBMISSION
- May 18, 20238-K
- May 5, 20238-K
- May 1, 20238-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROncorus, Inc. filings on SEC EDGAR
- 2SEC EDGAROncorus, Inc. filings on SEC EDGAR
- 3SEC EDGAROncorus, Inc. 10-K for fiscal 2019
- 4SEC EDGAROncorus, Inc. 10-K for fiscal 2020
- 5SEC EDGAROncorus, Inc. 10-K for fiscal 2021
- 6SEC EDGAROncorus, Inc. 10-Q for fiscal 2023
- 7SEC EDGAROncorus, Inc. 10-K for fiscal 2023
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARDouglas Fambrough, Board member
- 14SEC EDGAREric Rubin, Board member
- 15SEC EDGARBarbara Yanni, Board member
- 16SEC EDGARBriggs Morrison, Board member
- 17SEC EDGARCameron Wheeler, Board member
- 18SEC EDGARLuke Evnin, Board member
- 19SEC EDGARMary Kay Fenton, Board member
- 20SEC EDGARMitchell H. Finer, Board member
- 21SEC EDGARSpencer Nam, Board member
- 22SEC EDGARScott A. Canute, Board member